-+ 0.00%
-+ 0.00%
-+ 0.00%

*Turn Therapeutics: Interim Analysis Supports Expansion of GX-03 Phase 2 Study to a Broader Population of Atopic Dermatitis Patients >TTRX

Dow Jones·08/12/2026 20:35:00

Please log in to view news